Bacterial self-defence: how Escherichia coli evades serum killing.
about
Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the FieldEvidence for a LOS and a capsular polysaccharide in Capnocytophaga canimorsusPhenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.Diversity, virulence, and antimicrobial resistance of the KPC-producing Klebsiella pneumoniae ST307 clone.Therapies in early development for the treatment of urinary tract inflammation.Defining the mechanical determinants of Kingella kingae adherence to host cells.Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate.Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection.Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections.Editorial: Antimicrobial Peptides and Complement - Maximising the Inflammatory Response.Galactofuranose in Mycoplasma mycoides is important for membrane integrity and conceals adhesins but does not contribute to serum resistance.Mercury removal during growth of mercury tolerant and self-aggregating Yarrowia sppDevelopment and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission.Variant O89 O-Antigen of Is Associated With Group 1 Capsule Loci and Multidrug Resistance
P2860
Q26786281-F874062A-5AB0-44D4-8354-85756FE1E7EAQ28817422-763853AF-16FE-4690-AF67-1EA9ECEC1518Q35098186-B6AD06BF-CA62-4617-9108-29E6D3E1B945Q35187514-454A0FE0-15E1-4D44-A495-72478E4D6ADCQ38645716-1888064C-0614-4550-B852-F03068685C65Q38757968-DA2B0397-F892-440B-B8A7-09AA25C3E6C0Q40065911-9424A009-E225-441A-A5DA-6EDDF09D92A0Q40201620-546CE9D0-55AC-4B96-8E81-0631FBB5F9DEQ40276070-0933D372-8CFB-4C44-93F7-A3A45832DC47Q40730755-E4FC12D1-D021-456D-9D9C-5B18D403A94FQ40963870-8B55E29A-3FE6-4233-808E-EE52A92D9CB0Q41008176-EE888F0C-83EA-4B4D-B6BC-347E69053474Q41458806-270B25E7-3209-4FA9-84F4-96ED7A743E30Q47103928-974095C4-E76B-4BBB-BFEC-3FC585294D07Q55385864-6A28B29E-AEF1-4826-B449-2CC98D47BBB0Q58780723-BA904996-7EF0-4152-9A6D-6009F662E190
P2860
Bacterial self-defence: how Escherichia coli evades serum killing.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bacterial self-defence: how Escherichia coli evades serum killing.
@en
type
label
Bacterial self-defence: how Escherichia coli evades serum killing.
@en
prefLabel
Bacterial self-defence: how Escherichia coli evades serum killing.
@en
P2860
P356
P1476
Bacterial self-defence: how Escherichia coli evades serum killing
@en
P2093
Helen Miajlovic
Stephen G Smith
P2860
P356
10.1111/1574-6968.12419
P577
2014-03-24T00:00:00Z